Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Book
-
Chapter
HER2-Positive Metastatic Breast Cancer: First-Line Treatment
Prognoses for patients with breast cancer overexpressing the human epidermal growth factor receptor 2 (HER2) have markedly improved with the administration of anti-HER2-targeted therapy.